Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasm Metastasis × Thioguanine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Leukemia 34 Burkitt Lymphoma 11 Lymphoma 7 Leukemia, Myeloid, Acute 5 Leukemia, Biphenotypic, Acute 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Myelodysplastic Syndromes 4 Leukemia, Myelomonocytic, Chronic 4 Anemia, Refractory, with Excess of Blasts 4 Myeloproliferative Disorders 3 Leukemia, Monocytic, Acute 3 Recurrence 2 Neutropenia 2 Neoplasms 2 Neoplasm, Residual 2 Myelodysplastic-Myeloproliferative Diseases 2 Leukemia, Promyelocytic, Acute 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Down Syndrome 2 Dendritic Cell Sarcoma, Interdigitating 2 Brain Neoplasms 2 Anemia, Refractory 2 Thrombocytopenia 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Optic Nerve Glioma 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1

Interventions

pembrolizumab 134 Gemcitabine 122 Capecitabine 113 Fluorouracil 106 Paclitaxel 105 Oxaliplatin 96 Bevacizumab 95 Nivolumab 90 Leucovorin 89 Docetaxel 80 Radiosurgery 78 Irinotecan 78 Cisplatin 75 Carboplatin 74 Magnetic Resonance Spectroscopy 65 Cyclophosphamide 62 Cetuximab 60 Biopsy 54 Specimen Handling 52 Trastuzumab 50 Radiotherapy 48 Ipilimumab 44 Everolimus 41 Drug Therapy 40 Pemetrexed 39 Albumin-Bound Paclitaxel 39 130-nm albumin-bound paclitaxel 38 Doxorubicin 36 aldesleukin 35 Fulvestrant 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05276284 2026-01-14

TEMPLE

Rigshospitalet, Denmark

Phase 1/2 Completed

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡